First-in-class therapy targets 'undruggable' protein in hard-to-treat blood cancers

A first-in-class therapy to people MYC, 1 of the astir sought-after and hard targets successful crab biology, showed committedness successful hard-to-treat humor cancers, according to a caller preclinical survey from The University of Texas MD Anderson Cancer Center published successful Blood.